These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 27430109)

  • 1. Association of vascular endothelial growth factor expression with patohistological parameters of cutaneous melanoma.
    Gacević M; Jović M; Zolotarevski L; Stanojević I; Novaković M; Miller K; Šuljagić V; Mijušković Ž; Vojvodić D
    Vojnosanit Pregl; 2016 May; 73(5):449-57. PubMed ID: 27430109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical expression of VEGF, HIF1-a, and PlGF in malignant melanomas and dysplastic nevi.
    Konstantina A; Lazaris AC; Ioannidis E; Liossi A; Aroni K
    Melanoma Res; 2011 Oct; 21(5):389-94. PubMed ID: 21876459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical expression of vascular endothelial growth factor (VEGF) and C-KIT in cutaneous melanocytic lesions.
    Stefanou D; Batistatou A; Zioga A; Arkoumani E; Papachristou DJ; Agnantis NJ
    Int J Surg Pathol; 2004 Apr; 12(2):133-8. PubMed ID: 15173918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical expression of vascular endothelial growth factor, matrix metalloproteinase 2, and matrix metalloproteinase 9 in cutaneous melanocytic lesions.
    Simonetti O; Lucarini G; Brancorsini D; Nita P; Bernardini ML; Biagini G; Offidani A
    Cancer; 2002 Nov; 95(9):1963-70. PubMed ID: 12404291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minichromosome maintenance protein expression in benign nevi, dysplastic nevi, melanoma, and cutaneous melanoma metastases.
    Boyd AS; Shakhtour B; Shyr Y
    J Am Acad Dermatol; 2008 May; 58(5):750-4. PubMed ID: 18249467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of vascular endothelial growth factor in early cutaneous melanocytic lesion progression.
    Einspahr JG; Thomas TL; Saboda K; Nickolof BJ; Warneke J; Curiel-Lewandrowski C; Ranger-Moore J; Duckett L; Bangert J; Fruehauf JP; Alberts DS
    Cancer; 2007 Dec; 110(11):2519-27. PubMed ID: 17932890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of vascular endothelial growth factor expression in skin melanoma.
    Gajanin V; Krivokuća Z; Kostić K; Gajanin R; Sladojević I
    Vojnosanit Pregl; 2010 Sep; 67(9):747-54. PubMed ID: 20949875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphometric, DNA, and proliferating cell nuclear antigen measurements in benign melanocytic lesions and cutaneous malignant melanoma.
    Björnhagen V; Bonfoco E; Brahme EM; Lindholm J; Auer G
    Am J Dermatopathol; 1994 Dec; 16(6):615-23. PubMed ID: 7864299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beclin 1 and LC3 autophagic gene expression in cutaneous melanocytic lesions.
    Miracco C; Cevenini G; Franchi A; Luzi P; Cosci E; Mourmouras V; Monciatti I; Mannucci S; Biagioli M; Toscano M; Moretti D; Lio R; Massi D
    Hum Pathol; 2010 Apr; 41(4):503-12. PubMed ID: 20004946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of cytoplasmic p27 expression in human melanoma.
    Chen G; Cheng Y; Zhang Z; Martinka M; Li G
    Cancer Epidemiol Biomarkers Prev; 2011 Oct; 20(10):2212-21. PubMed ID: 21828232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of estrogen receptors in dysplastic nevi and malignant melanoma.
    Lecavalier MA; From L; Gaid N
    J Am Acad Dermatol; 1990 Aug; 23(2 Pt 1):242-6. PubMed ID: 2212119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia-inducible factors 1alpha and 2alpha are related to vascular endothelial growth factor expression and a poorer prognosis in nodular malignant melanomas of the skin.
    Giatromanolaki A; Sivridis E; Kouskoukis C; Gatter KC; Harris AL; Koukourakis MI
    Melanoma Res; 2003 Oct; 13(5):493-501. PubMed ID: 14512791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VEGF and VEGFR-2 immunohistochemistry in human melanocytic naevi and cutaneous melanomas.
    Pisacane AM; Risio M
    Melanoma Res; 2005 Feb; 15(1):39-43. PubMed ID: 15714119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of Vascular Endothelial Growth Factor (VEGF)-C and VEGF-D in the Progression of Cutaneous Melanoma.
    Špirić Z; Eri Ž; Erić M
    Int J Surg Pathol; 2015 Dec; 23(8):629-37. PubMed ID: 25911567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced expression of vascular endothelial growth factor in metastatic melanoma.
    Salven P; Heikkilä P; Joensuu H
    Br J Cancer; 1997; 76(7):930-4. PubMed ID: 9328154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression and prognostic significance of galectin-1 and galectin-3 in benign nevi and melanomas].
    Li ZW; Wang Y; Xue WC; Si L; Cui CL; Cao DF; Zhou LX; Guo J; Lu AP
    Zhonghua Bing Li Xue Za Zhi; 2013 Dec; 42(12):801-5. PubMed ID: 24507096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor expression in malignant melanoma: prognostic versus diagnostic usefulness.
    Bayer-Garner IB; Hough AJ; Smoller BR
    Mod Pathol; 1999 Aug; 12(8):770-4. PubMed ID: 10463478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD44 and variants in melanocytic skin neoplasms.
    Schaider H; Soyer HP; Heider KH; Hofmann-Wellenhof R; Zatloukal K; Smolle J; Kerl H
    J Cutan Pathol; 1998 Apr; 25(4):199-203. PubMed ID: 9609138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melanoma with benign melanocytic naevus components: reappraisal of clinicopathological features and prognosis.
    Kaddu S; Smolle J; Zenahlik P; Hofmann-Wellenhof R; Kerl H
    Melanoma Res; 2002 Jun; 12(3):271-8. PubMed ID: 12140384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of vascular endothelial growth factors and their receptors in malignant melanomas.
    Brychtova S; Bezdekova M; Brychta T; Tichy M
    Neoplasma; 2008; 55(4):273-9. PubMed ID: 18505336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.